Biochanin A Mitigates Oxidative Stress and Inflammation in Diabetic Myocardial Infarction: Insights From a Streptozotocin and Isoproterenol Rat Model
Cureus · 30.03.2025
DOI: 10.7759/cureus.81455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 30.03.2025. Verfasst von Umesh B Mahajan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, IND. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
INTRODUCTION: Diabetes mellitus (DM) significantly increases the risk and severity of myocardial infarction (MI), contributing to poor cardiovascular outcomes through oxidative stress, inflammation, and endothelial dysfunction. METHODS: This study evaluates the cardioprotective potential of biochanin A (BCA), a naturally occurring isoflavonoid with antioxidant and anti-inflammatory properties, in a streptozotocin (STZ) and isoproterenol (ISO)-induced model of diabetic myocardial infarction (DMI) in rats. Male Wistar rats were divided into five groups, including normal controls, STZ+ISO, and three BCA-treated groups (5, 10, and 20 mg/kg).
Results
BCA administration significantly improved electrocardiographic parameters by reducing ST height and QT interval prolongation (p < 0.05). It also reduced myocardial injury markers (lactate dehydrogenase (LDH), creatinine kinase on myocardial bundle (CK-MB), aspartate transaminase (AST), and cardiac troponin-T (cTn-T)) in a dose-dependent manner (p < 0.001). BCA normalized blood pressure, heart rate, and left ventricular function, improving maximum and minimum rate of ventricular contraction (+dP/dt, -dP/dt) (p < 0.01). Furthermore, BCA significantly decreased blood glucose levels and improved lipid profiles by lowering total cholesterol (TC), triglycerides (TG), and low-density lipoprotein (LDL) while increasing high-density lipoprotein (HDL) levels (p < 0.001). It suppressed inflammation by reducing tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β levels (p < 0.01). Oxidative stress markers, including malondialdehyde (MDA), were reduced, while antioxidant markers such as glutathione (GSH), superoxide dismutase (SOD), and catalase were increased (p < 0.001). BCA enhanced nuclear factor erythroid 2-related factor 2 (Nrf2) expression, promoting antioxidant defense. Histopathological analysis confirmed reduced myocardial injury and improved cardiac architecture.
Conclusion
These findings highlight BCA's potential as a therapeutic agent for managing DMI through its dual antioxidant and anti-inflammatory actions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, IND.
Zitieren
APA
Mahajan, U. B., & Goyal, S. (2025). Biochanin A Mitigates Oxidative Stress and Inflammation in Diabetic Myocardial Infarction: Insights From a Streptozotocin and Isoproterenol Rat Model. Cureus. https://doi.org/10.7759/cureus.81455
Vancouver
Mahajan UB, Goyal S. Biochanin A Mitigates Oxidative Stress and Inflammation in Diabetic Myocardial Infarction: Insights From a Streptozotocin and Isoproterenol Rat Model. Cureus. 2025. doi:10.7759/cureus.81455
BibTeX
@article{Mahajan2025,
author = {Mahajan, Umesh B and Goyal, Sameer},
title = {Biochanin A Mitigates Oxidative Stress and Inflammation in Diabetic Myocardial Infarction: Insights From a Streptozotocin and Isoproterenol Rat Model},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.81455}
}
EUVIMED